section name header

Footnotes

a Tested in dextrose 5%.

b Tested in sodium chloride 0.9%.

c Tested in bacteriostatic sodium chloride 0.9% preserved with benzyl alcohol 0.9%.

d Lyophilized formulation tested.

e Refer to Appendix for the composition of parenteral nutrition solutions. TNA indicates a 3-in-1 admixture, and TPN indicates a 2-in-1 admixture.

f Test performed using the formulation WITHOUT edetate disodium.

g Piperacillin component. Piperacillin in an 8:1 fixed-ratio concentration with tazobactam.

h Tested in both dextrose 5% and sodium chloride 0.9%.

i Ceftolozane component. Ceftolozane in a 2:1 fixed-ratio concentration with tazobactam.

j Meropenem component. Meropenem in a 1:1 fixed-ratio concentration with vaborbactam.

k Imipenem component. Imipenem in a 2:2:1 fixed-ratio concentration with cilastatin and relebactam.

l Sulbactam component. Sulbactam in a 1:1 fixed-ratio concentration with durlobactam.